0000000000067067

AUTHOR

Peter Boyle

0000-0001-6251-0610

showing 7 related works from this author

Curbing tobacco's toll starts with the professionals: World No Tobacco Day

2005

Economic growthbiologyHealth PersonnelTollPolitical scienceRolebiology.proteinHumansSmoking PreventionHealth FacilitiesHealth PromotionGeneral MedicineWorld Health OrganizationThe Lancet
researchProduct

Relation of childhood brain tumors to exposure of parents and children to tobacco smoke: The Search international case-control study

2002

The etiology of childhood brain tumors (CBTs) remains unknown. Tobacco smoke contains several known carcinogens and can induce DNA adducts in human placenta and hemoglobin adducts in fetuses. We present the results of an international case-control study to evaluate the association between CBTs and exposure of parents and children to cigarette smoke. The study was undertaken as part of the SEARCH program of the IARC. Nine centers in 7 countries were involved. The studies mainly covered the 1980s and early 1990s. Cases (1,218, ages 0-19 years) were children newly diagnosed with a primary brain tumor; there were 2,223 population-based controls. Most mothers who agreed to participate were inter…

Cancer ResearchPediatricsmedicine.medical_specialtyPregnancyeducation.field_of_studyPassive smokingbusiness.industryPopulationCase-control studyOdds ratiomedicine.disease_causemedicine.diseaseTobacco smokeOncologyEpidemiologymedicineRisk factorbusinesseducationInternational Journal of Cancer
researchProduct

Need for global action for cancer control.

2008

Malemedicine.medical_specialtyCancer ResearchInternational CooperationUterine cervix cancerDiseaseGlobal HealthWorld health03 medical and health sciences0302 clinical medicineCancer controlSDG 3 - Good Health and Well-beingNeoplasmsCancer screeningmedicineGlobal healthHumans030212 general & internal medicineGynecologyHealth Services Needs and DemandCancer preventionbusiness.industryHematologyPrimary Prevention/dk/atira/pure/subjectarea/asjc/2700/2730Risk analysis (engineering)Action (philosophy)Oncology030220 oncology & carcinogenesisFemalebusiness/dk/atira/pure/subjectarea/asjc/1300/1306Annals of oncology : official journal of the European Society for Medical Oncology
researchProduct

Kl3Semileptonic Form Factor from (2+1)-Flavor Lattice QCD

2008

We present the first results for the ${K}_{l3}$ form factor from simulations with $2+1$ flavors of dynamical domain wall quarks. Combining our result, namely, ${f}_{+}(0)=0.964(5)$ with the latest experimental results for ${K}_{l3}$ decays leads to $|{V}_{us}|=0.2249(14)$, reducing the uncertaintity in this important parameter. For the $O({p}^{6})$ term in the chiral expansion we obtain $\ensuremath{\Delta}f=\ensuremath{-}0.013(5)$.

QuarkPhysicsQuantum chromodynamicsParticle physics010308 nuclear & particles physicsCabibbo–Kobayashi–Maskawa matrixLattice field theoryForm factor (quantum field theory)General Physics and AstronomyLattice QCD01 natural sciencesDomain wall (magnetism)Lattice gauge theory0103 physical sciences010306 general physicsPhysical Review Letters
researchProduct

Kl3form factor withNf= 2 +1 dynamical domain wall fermions

2008

We present the latest results from the UKQCD/RBC collaborations for the Kl3 form factor from simulations with 2 + 1 flavours of dynamical domain wall quarks. Simulations are performed on lattices with two different volumes and four values of the light quark mass, allowing for an extrapolation to the chiral limit. The analysis includes a thorough investigation into the sources of systematic error in our fits. After interpolating to zero momentum transfer, we obtain f+(0) = 0.964(5) (or ?f = -0.013(5)) which, when combined with the latest experimental results for Kl3 decays, leads to |Vus| = 0.2249(14).

QuarkPhysicsHistoryParticle physicsCabibbo–Kobayashi–Maskawa matrixHigh Energy Physics::LatticeMomentum transferLattice field theoryExtrapolationForm factor (quantum field theory)FermionComputer Science ApplicationsEducationDomain wall (string theory)Journal of Physics: Conference Series
researchProduct

Tobacco: deadly in any form or disguise

2006

AdultMaleAdolescentbusiness.industrySmoking preventionSmokingMEDLINESmoking PreventionHealth PromotionGeneral MedicineMiddle AgedGlobal HealthHealth promotionEnvironmental healthTobaccoGlobal healthHumansMedicineFemaleMortalityChildbusinessAgedThe Lancet
researchProduct

Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32

2010

To identify susceptibility loci for non-Hodgkin lymphoma subtypes, we conducted a three-stage genome-wide association study. We identified two variants associated with follicular lymphoma at 6p21.32 (rs10484561, combined P = 1.12 × 10-29 and rs7755224, combined P = 2.00 × 10-19; r2 = 1.0), supporting the idea that major histocompatibility complex genetic variation influences follicular lymphoma susceptibility. We also found confirmatory evidence of a previously reported association between chronic lymphocytic leukemia/small lymphocytic lymphoma and rs735665 (combined P = 4.24 × 10-9). © 2010 Nature America, Inc. All rights reserved.

Chronic lymphocytic leukemiaFollicular lymphomaLocus (genetics)Genome-wide association studyHuman leukocyte antigenBiologyArticleMajor Histocompatibility Complex03 medical and health sciences0302 clinical medicinefollicular lymphomaRisk Factorshemic and lymphatic diseasesGeneticsmedicineHumansLymphoma Follicular030304 developmental biology0303 health sciencesLymphoma Non-HodgkinGenetic Variation16. Peace & justicemedicine.diseaseLeukemia Lymphocytic Chronic B-Cell3. Good healthLymphomaNon-Hodgkin's lymphomaLeukemia030220 oncology & carcinogenesisImmunologyDisease SusceptibilityGenome-Wide Association Study
researchProduct